These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8243228)

  • 1. [Changes in the fibrinolytic activity in hypertension and acute cerebral infarction].
    Guan KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun; 21(3):150-2, 186-7. PubMed ID: 8243228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
    Li F; Zhang G; Zhao W
    Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW; Catto AJ; Carter AM; Grant PJ
    Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis on the activity status of fibrinolytic system in Chinese patients with acute cerebral infarction].
    Zhang Y; Liu X; Cai Z
    Zhonghua Nei Ke Za Zhi; 1995 Aug; 34(8):518-21. PubMed ID: 8697908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
    Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
    J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
    Agren A; Wiman B; Schulman S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
    Mehta P; Parker RI
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White coat hypertension and haemostatic/fibrinolytic balance disorders.
    Makris T; Stavroulakis G; Papadopoulos D; Paizis I; Krespi P; Tsoukala C; Hatzizacharias A; Votteas V
    Eur Cytokine Netw; 2006 Jun; 17(2):137-41. PubMed ID: 16840033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
    Daniel WC; Meidell RS; Hillis LD; Lange RA
    Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.
    Jin L; Jin H; Zhang G; Xu G
    Clin Hemorheol Microcirc; 2000; 23(2-4):213-8. PubMed ID: 11321442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
    Yamada S; Yamada R; Ishii A; Ashikawa K; Kawamitsu H; Fujita K
    J Cardiol; 1996 Apr; 27(4):171-8. PubMed ID: 8642503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of fibrinolysis in essential hypertension.
    Ettenger MM; MacCarthy EP; Glas-Greenwalt P; Clyne DH; Pollak VE
    J Hypertens Suppl; 1984 Dec; 2(3):S175-8. PubMed ID: 6242555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator release in chronic venous hypertension due to heart failure.
    Keber I; Keber D; Stegnar M; Vene N
    Thromb Haemost; 1992 Sep; 68(3):321-4. PubMed ID: 1440498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in ovarian cancer.
    Ho CH; Yuan CC; Liu SM
    Gynecol Oncol; 1999 Dec; 75(3):397-400. PubMed ID: 10600296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.